Nanotechnology-Based Strategies for the Management of COVID-19: Recent Developments and Challenges.
Curr Pharm Des
; 27(41): 4197-4211, 2021.
Article
in English
| MEDLINE | ID: covidwho-1547089
ABSTRACT
COVID-19 is a respiratory disease caused by a newly identified coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since its inception in late December 2019, COVID-19 has led to a tremendous loss of human life worldwide. To overcome the unprecedented challenges posed by the COVID-19 pandemic to the public and economic health, strengthening the healthcare system is of utmost need. In this regard, research communities are putting efforts into developing an advanced healthcare system that could reduce the severe impacts of this pandemic. Nanotechnology is an advanced technology that has contributed significantly to produce powerful arsenals for the frontline warriors in this battle against COVID-19. It has offered opportunities for the development of fast and accurate point-of-care testing, efficient therapeutics and vaccines, potent sanitizers, facemasks, and personal protective equipment against SARS-CoV-2. However, associated toxicity, lengthy procedures of clinical trials, and uncertain health risks are some points that are still debatable. The present paper provides an overview of COVID-19 specific therapeutics and vaccines with an emphasis on nano-based strategies, which are significantly contributing towards the success of mitigation measures and strategies against COVID-19. Furthermore, the associated challenges, current limitations, and opportunities in this field are discussed.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Humans
Language:
English
Journal:
Curr Pharm Des
Journal subject:
Pharmacy
Year:
2021
Document Type:
Article
Affiliation country:
1381612827666210830105459
Similar
MEDLINE
...
LILACS
LIS